DrugCite
Search

METHYCOBAL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Methycobal Adverse Events Reported to the FDA Over Time

How are Methycobal adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Methycobal, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Methycobal is flagged as the suspect drug causing the adverse event.

Most Common Methycobal Adverse Events Reported to the FDA

What are the most common Methycobal adverse events reported to the FDA?

Basal Cell Carcinoma
7 (3.47%)
Vomiting
6 (2.97%)
Hypoglycaemia
5 (2.48%)
Drug Eruption
4 (1.98%)
Gingivitis
4 (1.98%)
Loss Of Consciousness
4 (1.98%)
Pneumocystis Jiroveci Infection
4 (1.98%)
Pneumonia Cytomegaloviral
4 (1.98%)
Renal Failure Acute
4 (1.98%)
Toxic Epidermal Necrolysis
4 (1.98%)
White Blood Cell Count Decreased
4 (1.98%)
Show More Show More
Blood Creatinine Increased
3 (1.49%)
Bronchial Secretion Retention
3 (1.49%)
Death
3 (1.49%)
Dizziness
3 (1.49%)
Dysphoria
3 (1.49%)
Lacunar Infarction
3 (1.49%)
Liver Disorder
3 (1.49%)
Nausea
3 (1.49%)
Subarachnoid Haemorrhage
3 (1.49%)
Amnesia
2 (.99%)
Bacteraemia
2 (.99%)
Blood Creatinine Decreased
2 (.99%)
C-reactive Protein Increased
2 (.99%)
Cardiac Failure
2 (.99%)
Disorientation
2 (.99%)
Disseminated Intravascular Coagulat...
2 (.99%)
Endocarditis
2 (.99%)
Epilepsy
2 (.99%)
Euphoric Mood
2 (.99%)
Gait Disturbance
2 (.99%)
Gamma-glutamyltransferase Increased
2 (.99%)
Haemoglobin Decreased
2 (.99%)
Hallucination
2 (.99%)
Hepatic Function Abnormal
2 (.99%)
Hypertension
2 (.99%)
Lymph Node Pain
2 (.99%)
Lymphocyte Count Decreased
2 (.99%)
Monocyte Count Decreased
2 (.99%)
Neutrophil Count Increased
2 (.99%)
Osteonecrosis
2 (.99%)
Pain
2 (.99%)
Pancytopenia
2 (.99%)
Platelet Count Decreased
2 (.99%)
Respiratory Failure
2 (.99%)
Sick Sinus Syndrome
2 (.99%)
Speech Disorder
2 (.99%)
Splenic Infarction
2 (.99%)
Stevens-johnson Syndrome
2 (.99%)
Toxic Skin Eruption
2 (.99%)
Transfusion-related Acute Lung Inju...
2 (.99%)
White Blood Cell Count Increased
2 (.99%)
Abdominal Pain Lower
1 (.5%)
Abdominal Pain Upper
1 (.5%)
Anorexia
1 (.5%)
Aspartate Aminotransferase Increase...
1 (.5%)
Blast Cell Proliferation
1 (.5%)
Blood Bilirubin Increased
1 (.5%)
Blood Glucose Increased
1 (.5%)
Blood Lactate Dehydrogenase Increas...
1 (.5%)
Blood Potassium Increased
1 (.5%)
Blood Urea Increased
1 (.5%)
Cerebral Haemorrhage
1 (.5%)
Chest Discomfort
1 (.5%)
Chromaturia
1 (.5%)
Coma
1 (.5%)
Continuous Haemodiafiltration
1 (.5%)
Creatinine Renal Clearance Decrease...
1 (.5%)
Deafness
1 (.5%)
Decubitus Ulcer
1 (.5%)
Dementia
1 (.5%)
Diarrhoea
1 (.5%)
Drug Exposure During Pregnancy
1 (.5%)
Drug Ineffective
1 (.5%)
Drug Rash With Eosinophilia And Sys...
1 (.5%)
Erythema
1 (.5%)
Gastrointestinal Haemorrhage
1 (.5%)
Generalised Erythema
1 (.5%)
Glycosylated Haemoglobin Increased
1 (.5%)
Haematocrit Decreased
1 (.5%)
Haemorrhage Subcutaneous
1 (.5%)
Hepatitis Acute
1 (.5%)
Histiocytosis Haematophagic
1 (.5%)
Hyperammonaemia
1 (.5%)
Hyperglycaemia
1 (.5%)
Idiopathic Thrombocytopenic Purpura
1 (.5%)
Keratitis
1 (.5%)
Leukoencephalopathy
1 (.5%)
Listeria Sepsis
1 (.5%)
Lymphadenopathy
1 (.5%)
Lymphopenia
1 (.5%)
Malaise
1 (.5%)
Mucosal Erosion
1 (.5%)
Nodal Rhythm
1 (.5%)
Oedema Peripheral
1 (.5%)
Off Label Use
1 (.5%)
Oliguria
1 (.5%)
Oral Herpes
1 (.5%)
Osteomyelitis
1 (.5%)
Pelvic Venous Thrombosis
1 (.5%)
Pemphigoid
1 (.5%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Methycobal, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methycobal is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Methycobal

What are the most common Methycobal adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Methycobal, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methycobal is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Methycobal According to Those Reporting Adverse Events

Why are people taking Methycobal, according to those reporting adverse events to the FDA?

Neuropathy Peripheral
197
Hypoaesthesia
54
Product Used For Unknown Indication
48
Prophylaxis
47
Diabetic Neuropathy
27
Herpes Zoster
24
Show More Show More
Pain
21
Drug Use For Unknown Indication
19
Post Herpetic Neuralgia
17
Dizziness
14
Multiple Myeloma
14
Spinal Osteoarthritis
13
Asthenopia
12
Vitamin Supplementation
12
Nerve Injury
11
Back Pain
9
Diabetes Mellitus
9
Spinal Column Stenosis
9
Lumbar Spinal Stenosis
8
Orthostatic Hypotension
8
Amyotrophic Lateral Sclerosis
8
Neuralgia
8
Anaemia
8
Scleroderma
7
Menieres Disease
7
Hypovitaminosis
6
Multiple Sclerosis
6
Keratitis
6
Hyperlipidaemia
5
Nervous System Disorder
5
Relapsing-remitting Multiple Sclero...
5
Disease Complication
5
Rheumatoid Arthritis
5
Sciatica
4
Cervical Myelopathy
4
Trigeminal Neuralgia
4
Neurosis
4
Diabetic Nephropathy
4
Cerebral Infarction
4
Vitamin B12 Deficiency
4
Type 2 Diabetes Mellitus
4
Metastatic Renal Cell Carcinoma
4
Arteriosclerosis Obliterans
3
Vertigo
3
Lacunar Infarction
3
Nervousness
3
Herpes Simplex
3
Dysgeusia
2
Angina Pectoris
2
Intervertebral Disc Protrusion
2
Macular Degeneration
2

Methycobal Case Reports

What Methycobal safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Methycobal. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Methycobal.